ARCHIVES

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

This article is from The Cancer Letter archive.

Vol. 11 No. 37 | September 27, 1985

Download PDF Visit The Full Archive

Related Articles

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

NCI Plans Research To Reduce Cancer Disparities.

June 16, 2000

HHS News: Leavitt Confirmed As HHS Secretary.

January 28, 2005

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Agency Asks GnRH Sponsors To Add Warnings On Labels

October 22, 2010